Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 4 of 4)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
23-Nov-09Reuters Investment ProfileN/ATapestry Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
28-Oct-09Global Markets DirectGlobal Markets DirectTapestry Pharmaceuticals, Inc. Financial Analysis Review12$300  View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Industry Report for DRUGS18$49  View Abstract
29-Aug-08ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for TPPH13$25  View Abstract
Independent Reports (Showing 1 to 4 of 4)
Release
Date [down]		 Contributor Author Title Pages Price More Info
23-Nov-09Reuters Investment ProfileN/ATapestry Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
28-Oct-09Global Markets DirectGlobal Markets DirectTapestry Pharmaceuticals, Inc. Financial Analysis Review12$300View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Industry Report for DRUGS18$49View Abstract
29-Aug-08ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for TPPH13$25View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.